Remission InductionPharmacologyPharmacology, ClinicalRemission, SpontaneousDrug Screening Assays, AntitumorAntineoplastic AgentsXenograft Model Antitumor AssaysTreatment OutcomeAntibiotics, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorRecurrenceLeukemia P388Mice, NudeCytarabineDose-Response Relationship, DrugNeoplasm TransplantationNeoplasms, ExperimentalCyclophosphamideSarcoma 180Combined Modality TherapyNeoplasmsLeukemia, Myeloid, AcuteMelanoma, ExperimentalTime FactorsDoxorubicinImmunotherapyDrug Administration ScheduleDaunorubicinAntibodies, MonoclonalTumor Cells, CulturedVincristineCancer VaccinesMice, Inbred BALB CLeukemia L1210Precursor Cell Lymphoblastic Leukemia-LymphomaPrednisoneMethotrexateMice, Inbred C57BLFollow-Up StudiesDrug SynergismTransplantation, AutologousPrednisolonePrognosisImmunotherapy, AdoptiveLeukemia, LymphoidBone Marrow TransplantationDisease-Free SurvivalLeukemiaDrug Therapy, CombinationApoptosisLeukemia, MyeloidAntineoplastic Agents, PhytogenicDrug EvaluationSurvival AnalysisImmunosuppressive AgentsAntigens, NeoplasmCell ProliferationEtoposideMice, SCIDBone MarrowDrug Evaluation, PreclinicalNephrotic SyndromeClinical Trials as TopicHematopoietic Stem Cell TransplantationMesalamineEnediynesCisplatinAdministration, OralTransplantation, HomologousAntibodies, Monoclonal, Murine-DerivedSurvival RateNeoplasm, ResidualColitis, UlcerativeTransplantation, HeterologousLung NeoplasmsAntirheumatic Agents6-MercaptopurineThioguanineInjections, IntralesionalAsparaginaseAcute DiseaseInhibitory Concentration 50Molecular StructureMelanomaLymphoma, Non-HodgkinTerminology as TopicCytotoxicity, ImmunologicCarcinoma, Lewis LungCell SurvivalIdarubicinLigandsLeukemia, Promyelocytic, AcuteColonic NeoplasmsSalvage TherapyDrug DesignStructure-Activity RelationshipGenetic TherapyT-Lymphocytes, CytotoxicFlow Cytometry